...
首页> 外文期刊>European journal of gynaecological oncology >Malignant mixed mullerian tumor of the cervix including components of a rhabdomyosarcoma:case report and literature review
【24h】

Malignant mixed mullerian tumor of the cervix including components of a rhabdomyosarcoma:case report and literature review

机译:子宫颈恶性混合苗勒氏瘤,包括横纹肌肉瘤的成分:病例报告及文献复习

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Malignant mixed mesodermal tumors (MMMTs) are composed of carcinomatous and sarcomatous components and have an aggressive metastatic potential, resulting in a poor prognosis. MMMTs of gynecologic origin typically arise from either the ovary or the uterus, and MMMTs of the cervix are extremely rare. Due to the rarity of MMMTs arising from the cervix, there is no consensus regarding treatment, prognosis, and outcome; however, aggressive surgical cytoreduction, combined with adjuvant platinum-based chemotherapy and/or radiotherapy, is recommended as the treatment of choice for MMMTs of the cervix. Cervical MMMTs are more often confined to the uterus at the time of diagnosis and frequently have non-glandular epithelial components. For these reasons, MMMTs of the cervix may have a better prognosis compared to the uterine counterparts. A case of an immunohistochem-ically confirmed primary MMMT of the cervix, including components of a rhabdomyosarcoma, is reported.
机译:恶性混合性中胚层肿瘤(MMMT)由癌性和肉瘤性成分组成,具有侵袭性转移潜能,预后不良。妇科起源的MMMT通常来自卵巢或子宫,而子宫颈的MMMT极为罕见。由于宫颈引起的MMMT很少,因此在治疗,预后和预后方面尚无共识。但是,建议将积极的外科细胞减灭术与基于铂的辅助化疗和/或放疗相结合,作为宫颈MMMT的治疗选择。宫颈MMMT在诊断时通常局限于子宫内,并且经常具有非腺上皮成分。由于这些原因,与子宫对应物相比,子宫颈的MMMTs可能具有更好的预后。报道了一例经免疫组织化学证实为子宫颈的MMMT,包括横纹肌肉瘤的成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号